Chong Hua Hospital Mandaue Launches the Varian Halcyon™ with HyperSight™

Chong Hua Hospital Mandaue formally conducted the Grand Launch of the Varian Halcyon™ with HyperSight™ Linear Accelerator on February 18, 2026, marking another major step forward in its commitment to patient-centered cancer care. Centered on the theme “Advancing Image Guided Radiotherapy: HyperPrecise, HyperCare, HyperSight,” the event highlighted the hospital’s continued advancement in technology to better serve patients across the region.

The program opened with a welcome address from Dr. Helen S. Po, President and CEO of Chong Hua Hospitals, reaffirming the organization’s dedication to innovation and compassionate care. Leaders from Siemens Healthineers and Varian also shared insights into the technology behind Halcyon, emphasizing its design for confidence, efficiency, and precision in modern radiotherapy.

Medical experts from Chong Hua Hospitals underscored how HyperSight’s advanced imaging capabilities enhance tumor visualization, enabling more accurate and efficient radiation delivery while helping protect surrounding healthy tissues. The event concluded with a message from Dr. Maria Virginia S. Abalos, Medical Director of Chong Hua Hospital Mandaue, reinforcing the hospital’s mission to continually elevate the standard of cancer care.

The Halcyon™ with HyperSight™ represents more than an equipment upgrade. It reflects Chong Hua Hospital Mandaue’s promise to put patients first—ensuring safer treatments, improved comfort, and greater confidence throughout the cancer journey.

Through its continued pursuit of innovation in cutting-edge technology and clinical expertise, Chong Hua Hospital Mandaue continues to strengthen its commitment to delivering advanced, compassionate, and patient-centered cancer care.